Clinical Development Strategy and Technology

As profit and regulatory compliance pressures increase, life science companies are desperately seeking ways to decrease the cost and manage the risk of their clinical trials. Health Industry Insights' Clinical Development Strategy and Technology service provides life science companies with the necessary insight to increase their operational focus and sharpen their study planning and execution skills. This Health Industry Insights service provides a forward-looking analysis of IT technologies on the critical path and how they are being adopted all along the clinical development value chain. In addition to qualitative assessment, this service includes quantitative market sizing and forecasts to provide a complete picture of the processes and technologies that impact clinical development.

Approach

This service develops comprehensive data and unique analysis through focused topical surveys, secondary research, and insights from industry experts, practitioners, and vendors. To ensure relevance, Health Industry Insights' analysts work with subscribers to identify and prioritize specific topics to be covered in research reports.

Topics Addressed

Throughout the year, this service will address the following topics:

  • Clinical performance management and metrics; Clinical data management
  • Evolution toward adaptive trials
  • Achieving innovation and optimization of clinical trials IT infrastructure
  • Cost containment and risk assessment in clinical development
  • eClinical technology landscape, including integration with electronic health record (EHR) and other healthcare IT systems
  • Critical tools and systems: EDC, ePRO, CTMSs, CDMSs
  • Best practices in clinical trials management and IT
  • Pharmacovigilance and drug safety
  • Regulatory compliance issues and data integration standards: CDISC, HL 7, ICH

Key Questions Answered

Our research addresses the following issues that are critical to your success:

  • How can both the cost and the risk of clinical trials be managed while maximizing time to market and data quality?
  • What are the trends in technologies for trial design, patient recruitment, and site monitoring, and how will these trends affect end users in medical device companies and the pharmaceutical industry?
  • How can regulatory compliance be achieved while staying on time and within budget?
  • What are the key software and IT infrastructure issues in clinical development?
  • What are the key issues and best practices in data collection, data validation, and reporting?
  • What are the best practices and tools to use to optimize trial management through accelerating patient and investigator recruitment, managing sites efficiently, and balancing the portfolio of trials?
  • What are the best practices seen from companies leading the implementation of IT in clinical trials?
  • How do I ensure that my company's use of IT in clinical trials compares favorably with that of my competitors?

Who Should Subscribe

The adoption of eClinical technologies is rapidly moving from a tactical, project-based technology acquisition process to a strategic, enterprise-wide investment methodology. As a result, the insights provided from Health Industry Insights' Clinical Development Strategy and Technology service are beneficial to a growing number of individuals in the life science community, including chief information officers (CIOs), eClinical technology vendors, clinical operations, IT executives, and clinical investigators.

Return on Research Investment

Core Benefits for Technology Buyers

  • A clear view into the benefits, as well as the risks, of adopting eClinical technologies
  • The ability to select best-in-class solutions, data interchange standards, and technology vendors
  • Strategies to maximize your investment in existing technologies

Core Benefits for Technology Solution Providers

  • An assessment of the market opportunity for eClinical technology solutions
  • Unbiased insight from key opinion leaders in the industry
  • Increased market exposure and competitive intelligence

Standard Subscription Deliverables

Health Industry Insights values building client relationships and strives to foster a partnership with each client through continuous analyst interaction; concise delivery of current, timely, and relevant research; as well as custom research when needed. Each advisory service delivers strategic research covering business and technology issues. A summary of the basic service deliverables available to subscribers includes the following:

  • Analyst inquiry time specific to the advisory service area
  • 24 x 7 research access via healthindustry-insights.com
  • Discounted admission to specific Health Industry Insights or IDC conferences
  • Complimentary forum invitations (Webcasts, telebriefings, industry briefings)
  • Dedicated client service representatives

Lead Analyst

This service is led by Alan S. Louie, Ph.D., research director. A recognized thought leader in both the health and life sciences industries, Dr. Louie is a frequently sought-after speaker at top industry events, including Bio-IT World Conference, DIA, and Drug Discovery Technology World Congress. He brings more than 23 years of technical, product development, and business consulting experience from the diagnostics and biotechnology industries.

Related Offerings

Related offerings to our industry-specific research practices include IT Spending Guides - segmented regional and country-level analysis by solution area; Go-To-Market Services (GMS) - a modular set of deliverables to assist clients in extending their market reach, validating their market strategy, and producing more responsive customer-centric marketing campaigns; Global IT Advisor (GITA) - a flexible, cross-disciplinary research service providing granularity in market information and analysis across a wide range of technology areas; and IT Management Service (ITMS) - a best-practices research service covering IT governance, portfolio management, vendor procurement, and more. In addition, Health Industry Insights experts are available for individualized consulting engagements to address specific challenges or to customize the results of our syndicated research offerings.